No Data
No Data
Guizhou Bailing (002424.SZ) was approved as the first grade 2 protected variety of traditional Chinese medicine
Guizhou Bailing (002424.SZ) announced, recently, the China Drug Administration (“State Drug Administration”)...
Five listed companies including Jingu Co., Ltd. announced the chairman's proposal to repurchase shares after the market
Gelonghui, April 17 | According to incomplete statistics, five A-share listed companies, including Yongan Bank, Huifa Foods, Guangfeng Technology, Jingu Co., Ltd., and Minde Electronics announced that their chairmen proposed to repurchase shares after the market. In addition, Guizhou Bailing plans to change the use of some of the shares that have already been repurchased. The use of the repurchased shares will be changed from “for employee stock ownership plans or equity incentives” to “for cancellation and corresponding reduction of registered capital.” Jiang Han New Materials plans to raise the maximum share repurchase price from no more than 23.5 yuan/share to no more than 25 yuan/share.
Guizhou Bailing (002424.SZ): Accumulated cost of 84.621 million yuan to buy back 0.83% of shares
Gelonghui, March 4, 丨 Guizhou Bailing (002424.SZ) announced that as of February 29, 2024, the total number of shares repurchased by the company through centralized bidding transactions through the stock repurchase special securities account was 11,668,812 shares, accounting for 0.83% of the company's current total share capital. The highest transaction price was 8.22 yuan/share, the minimum transaction price was 6.59 yuan/share, and the total transaction amount was 84.621 million yuan (excluding transaction fees).
Express News | Recently, wildfires have occurred in many parts of Guizhou. Local listed companies responded that there was no impact on the cultivation and procurement of Chinese herbal medicines
Express News | There have been frequent wildfires in many parts of Guizhou recently, and many local listed pharmaceutical companies have responded: there is no impact on the supply of medicinal herbs
Guizhou Bailing (002424.SZ): “Multi-center clinical research and mechanism discussion on the prevention of diabetes and retinal complications with the Miao Drug Tangning Tongluo Tablets” passed the acceptance
<国家中医药管理局科技司关于2021年度中医药科学技术研究专项部分课题验收结果的通知>Gelonghui, February 19, Guizhou Bailing (002424.SZ) announced that the company (recently received the “Notice on Forwarding” from the Guizhou Provincial Administration of Traditional Chinese Medicine), according to the “Notice of the Science and Technology Department of the State Administration of Traditional Chinese Medicine on the Acceptance Results of the 2021 Traditional Chinese Medicine Science and Technology Research Special Topics” (China Traditional Chinese Medicine Science and Technology Letter [2024] No. 28), after expert review and combined with the completion of the assessment indicators, the company “Miaoyao Duangning” Tongluo tablets to prevent diabetes and vision
No Data